Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
Background: The gut microbiota is emerging as a pivotal player in the pathogenesis of many non-communicable diseases. Thus, it has been proposed as a new diagnostic and therapeutic target.Aim and scope: This Special Issue will focus on the microbiome as a potential target of new personalized therapi...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (280 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993573552604498 |
---|---|
ctrlnum |
(CKB)5470000001631723 (oapen)https://directory.doabooks.org/handle/20.500.12854/94490 (EXLCZ)995470000001631723 |
collection |
bib_alma |
record_format |
marc |
spelling |
Laterza, Lucrezia edt Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine Targeting the Microbiome for Disease Diagnosis and Therapy Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (280 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Background: The gut microbiota is emerging as a pivotal player in the pathogenesis of many non-communicable diseases. Thus, it has been proposed as a new diagnostic and therapeutic target.Aim and scope: This Special Issue will focus on the microbiome as a potential target of new personalized therapies or diagnostic tools.History: In recent decades, the gut microbiome has been deeply investigated, and many studies have provided new information on the role of dysbiosis in many gastrointestinal and extra-gastrointestinal diseases. Recently, in addition to its phylogenetic characterization, new information has become available regarding the function of the gut microbiota, thanks to proteomic and metabolomic analyses.Cutting-edge research: The therapeutic modulation of the gut microbiota based on different strategies, including diet modification, antibiotics, prebiotics, probiotics, and, last but not least, fecal microbiota transplantation, has been tested for the treatment of various diseases. Recently, the possible applications and modalities of gut microbiota modulation have been increasingly expanding.We have collected original clinical or pre-clinical research papers and reviews focusing on the use of the microbiome for disease diagnosis, monitoring, or therapy and suggesting new possible gut microbiota-based approaches for personalized care. English Medicine bicssc Graves-Basedow's diseases Hashimoto's thyroiditis autoimmunity gut microbiota irritable bowel syndrome microbiota microbiome food components nutrients hematopoietic stem cell transplantation fecal microbiota transplantation aGvHD antibiotic-resistant bacteria cystic fibrosis rabbits intestinal dysbiosis feces microbiome beta-blocker hemodialysis next-generation sequencing propensity score matching methods violin plots random sampling analytical reproducibility fecal matter transplantation data disease subtypes personalized medicine maltodextrin dip test gallstone disease 16S rDNA gene diversity blood biochemical characteristics mesothelioma 16S RNA sequencing species probiotics and gut disease probiotics and acute diverticulitis probiotics and diverticular disease probiotics mechanism of action IgA Nephropathy rifaximin α1KI-CD89Tg mice children intermittent hypoxemia obstructive sleep apnea tonsil weight status oral microbiota rheumatology diseases biomarkers artificial intelligence machine learning rheumatoid arthritis Sjogren's syndrome systemic lupus erythematosus endometrial cancer endometrial microbiome gut microbiome dysbiosis estrogen metabolism estrobolome inflammation antitumour treatment prebiotics probiotics schizophrenia depression anxiety functional genes thymoma genera driver mutation cardiovascular diseases critically ill intestinal permeability recurrent cystitis 3-0365-5612-5 Laterza, Lucrezia oth |
language |
English |
format |
eBook |
author2 |
Laterza, Lucrezia |
author_facet |
Laterza, Lucrezia |
author2_variant |
l l ll |
author2_role |
Sonstige |
title |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
spellingShingle |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
title_sub |
New Frontiers for Personalized Medicine |
title_full |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
title_fullStr |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
title_full_unstemmed |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
title_auth |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
title_alt |
Targeting the Microbiome for Disease Diagnosis and Therapy |
title_new |
Targeting the Microbiome for Disease Diagnosis and Therapy |
title_sort |
targeting the microbiome for disease diagnosis and therapy new frontiers for personalized medicine |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (280 p.) |
isbn |
3-0365-5611-7 3-0365-5612-5 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT laterzalucrezia targetingthemicrobiomefordiseasediagnosisandtherapynewfrontiersforpersonalizedmedicine AT laterzalucrezia targetingthemicrobiomefordiseasediagnosisandtherapy |
status_str |
n |
ids_txt_mv |
(CKB)5470000001631723 (oapen)https://directory.doabooks.org/handle/20.500.12854/94490 (EXLCZ)995470000001631723 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Targeting the Microbiome for Disease Diagnosis and Therapy New Frontiers for Personalized Medicine |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652572431351808 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05004nam-a2201213z--4500</leader><controlfield tag="001">993573552604498</controlfield><controlfield tag="005">20231214133206.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202212s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-5611-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000001631723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/94490</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000001631723</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Laterza, Lucrezia</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting the Microbiome for Disease Diagnosis and Therapy</subfield><subfield code="b">New Frontiers for Personalized Medicine</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Targeting the Microbiome for Disease Diagnosis and Therapy </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (280 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: The gut microbiota is emerging as a pivotal player in the pathogenesis of many non-communicable diseases. Thus, it has been proposed as a new diagnostic and therapeutic target.Aim and scope: This Special Issue will focus on the microbiome as a potential target of new personalized therapies or diagnostic tools.History: In recent decades, the gut microbiome has been deeply investigated, and many studies have provided new information on the role of dysbiosis in many gastrointestinal and extra-gastrointestinal diseases. Recently, in addition to its phylogenetic characterization, new information has become available regarding the function of the gut microbiota, thanks to proteomic and metabolomic analyses.Cutting-edge research: The therapeutic modulation of the gut microbiota based on different strategies, including diet modification, antibiotics, prebiotics, probiotics, and, last but not least, fecal microbiota transplantation, has been tested for the treatment of various diseases. Recently, the possible applications and modalities of gut microbiota modulation have been increasingly expanding.We have collected original clinical or pre-clinical research papers and reviews focusing on the use of the microbiome for disease diagnosis, monitoring, or therapy and suggesting new possible gut microbiota-based approaches for personalized care.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Graves-Basedow's diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hashimoto's thyroiditis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoimmunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gut microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">irritable bowel syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">food components</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nutrients</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hematopoietic stem cell transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fecal microbiota transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aGvHD</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic-resistant bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cystic fibrosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rabbits</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestinal dysbiosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">feces microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">beta-blocker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hemodialysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next-generation sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">propensity score matching methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">violin plots</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">random sampling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">analytical reproducibility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fecal matter transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">data disease subtypes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">maltodextrin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dip test</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gallstone disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">16S rDNA gene diversity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood biochemical characteristics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesothelioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">16S RNA sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics and gut disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics and acute diverticulitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics and diverticular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics mechanism of action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IgA Nephropathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rifaximin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α1KI-CD89Tg mice</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">children</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intermittent hypoxemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obstructive sleep apnea</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tonsil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">weight status</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oral microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheumatology diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">artificial intelligence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">machine learning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rheumatoid arthritis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sjogren's syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systemic lupus erythematosus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endometrial cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endometrial microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gut microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dysbiosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">estrogen metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">estrobolome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitumour treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prebiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">schizophrenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">depression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anxiety</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">functional genes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thymoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genera</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">driver mutation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">critically ill</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestinal permeability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">recurrent cystitis</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5612-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laterza, Lucrezia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:46:15 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-01-09 04:44:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5341785350004498&Force_direct=true</subfield><subfield code="Z">5341785350004498</subfield><subfield code="b">Available</subfield><subfield code="8">5341785350004498</subfield></datafield></record></collection> |